Mr. Michael Martinz reports

KANEH BOSM BIOTECHNOLOGY PROVIDES CORPORATE UPDATE

Kaneh Bosm Biotechnology Inc. has closed the definitive agreement with Marathon Global Inc. as previously announced on June 26, 2018, to acquire the remaining 50 per cent of the issued and outstanding share capital of Marathon.

The company has issued 15 million common shares to certain shareholders of Marathon in exchange for the remaining 8.5 million shares of Marathon.

The company has also paid a finder's fee of 1.2 million shares to an arm's-length party in connection with the Marathon transaction.

Marathon has an exclusive agreement with Cosmos Holdings Inc., a European-based pharmaceutical distributor, to procure and distribute medical cannabis products and all cannabis derivatives for clients of Cosmos in approved countries within its distribution network of 110 clients, representing approximately 35,000 pharmacies in 16 countries.

This relationship brings an unparalleled ability to supply the overwhelming demand for cannabis and cannabis extracts in Europe as Cosmos brings generations worth of experience and relationships to Kaneh Bosm.

The company also announces that it has closed the transaction with Canna Colombia Holdings Inc. to acquire 100 per cent of its issued and outstanding share capital, as previously announced on June 21, 2018.

Pursuant to the terms of the Canna Colombia transaction, the company has issued 30 million shares and it has paid $2-million (U.S.).

The company has paid a finder's fee of 2.4 million shares to an arm's-length party in connection with the Canna Colombia transaction.

Canna Colombia, through its wholly owned Colombian subsidiary, Cannabis Medical Group SAS, holds licences to cultivate, produce, hold, sell and export cannabis and its byproducts.

All securities issued pursuant to the Marathon transaction and securities issued as finders' fees will have a hold period expiring on Dec. 29, 2018.

The company also announces the appointment of Brendan Purdy to its board of directors and Eugene Beukman has been appointed as the company's chief executive officer.

Mr. Purdy is a practising securities lawyer focused on technology, cannabis and resource issuers. In his private practice, he has developed domestic and international experience with respect to public companies, reverse takeovers, mergers and acquisitions (M&A), and many facets fundamental to the Canadian capital markets. Prior to receiving his J.D. from the common-law section at the University of Ottawa, Mr. Purdy completed a bachelor of management and organizational studies degree from the University of Western Ontario, majoring in finance and administration. Mr. Purdy serves as a director of a number of CSR- and TSX Venture Exchange-listed companies.

The appointment follows the resignations of Rudy de Jonge as the company's chief executive officer and as a director effective immediately. Kaneh Bosm would like to thank Mr. de Jonge for his many years of service to the company and wishes him well with his future endeavours.

We seek Safe Harbor.